Patent · US Active

(3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amine

US7781441B2 · kind B2 · utility

2Cited by

1References

24Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Alexander Alanine · Schlierbach, FR
Luca Gobbi · Muttenz, CH
Sabine Kolczewski · Lörrach, DE
Thomas Luebbers · Soest, DE
Jens-Uwe Peters · Weil am Rhein, DE
Lucinda Steward · Basel, CH

Key dates

Filing date	Apr 27, 2006
Grant date	Aug 24, 2010
Priority date	—
Expiry date	Apr 3, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula Iwherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.